Morphic Medical


Developer of an endoscopically delivered temporary duodenal-jejunal bypass liner intended to improve glycemic control and induce weight loss in patients with type 2 diabetes and obesity. The company conducts multi-center clinical studies, maintains a patent portfolio covering gastrointestinal sleeve and anchoring technologies, and pursues regulatory approvals and international commercialization.

Industries

health-care
hospital-650c
medical-device
product-research

Nr. of Employees

small (1-50)

Morphic Medical

Boston, Massachusetts, United States, North America


Products

Temporary duodenal-jejunal bypass liner (endoscopic intestinal sleeve)

A 60 cm impermeable, flexible sleeve implanted endoscopically in the proximal small intestine to create a physical barrier between intestinal receptors and ingested food, intended to improve glycemic control and induce weight loss during temporary placement (up to ~12 months).


Services

Clinical trial conduct and patient enrollment (STEP-1 and other studies)

Organization and management of investigator-led and company-sponsored clinical studies, site coordination, patient screening, monitoring and follow-up visits at specified clinical sites in the US and internationally.

Expertise Areas

  • Endoscopic device development
  • Clinical trial management and multi-center studies
  • Regulatory compliance and CE marking
  • Gastrointestinal implant and anchoring technologies
  • Show More (5)

Key Technologies

  • Endoscopic delivery of intestinal sleeves
  • Duodenal-jejunal bypass liner (temporary intestinal sleeve)
  • Gastrointestinal anchoring mechanisms
  • Fluoropolymer implantable materials
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.